DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20182327

Combination of mifepristone and misopristol in early fetal demise

Atmajit Singh Dhillon, Karminder Kaur Dhillon

Abstract


Background: Generally misopristol alone is used in cases of early fetal demise successfully. However to further enhance the success rate a combination of mifepristone along with misopristol can be used. This results in avoiding anesthesia, surgery and operating theater resources, thus being economically viable and results in an overall greater patient satisfaction levels also. Globally, there is a general trend to grant patient greater autonomy in their treatment plan, minimize intervention levels, shorter hospital stay and quicker return to normal schedule and enhanced patient satisfaction levels.

Methods: 100 patients with early fetal demise, who reported to a tertiary care service hospital were prospectively evaluated. An oral dose of mifepristone 200 mg stat and 48 hours later misoprostol 800 μg was inserted vaginally. Three hours following the first dose, two further doses of 400 μg misoprostol, was administered vaginally at 3 hours intervals. Repeat medical regime was offered with misoprostol patients who failed to pass products of conception. Success was defined as complete uterine evacuation within 3 days, without the need for surgical evacuation.

Results: The overall success rate of medical management was 84%. Mifepristone alone induced natural expulsion of products of conception in (40%) patients complained of heavy bleeding within 48 hours of mifepristone administration alone and in 29 (29%) patients complete miscarriage was confirmed on ultrasound scan. Of the 68 women who were symptomatic at presentation the medical regime failed in 28 (41%), compared with five (16%) failures of the 32 who were asymptomatic. Of the 25 women who had surgical evacuation, eight required an emergency curettage for bleeding.

Conclusions: Combination of oral mifepristone along with vaginal misopristol is a simple, safe and effective means of treating early fetal demise, and is an effective alternative method to expectant and surgical options.


Keywords


Mifepristone, Misopristol, Missed abortion

Full Text:

PDF

References


Hemminki, E. Treatment of miscarriage: current practice and rationale. Obstet Gynecol. 1998;179:397-8.

Hughes J, Ryan M, Hinshaw K, Henshaw R, Rispin R, Templeton A, et al. The costs of treating miscarriage: a comparison of medical and surgical management. Br J Obstet Gynaecol. 1996;103:1217-21.

Jurkovic D, Ross JA, Nicolaides KH. Expectant management of missed miscarriage. Br. J. Obstet Gynaecol. 1998;105:670-1.

Creinin MD, Moyer R, Guido R. Misoprostol for medical evacuation of early pregnancy failure. Obstet Gynecol. 1997;89:768-72.

Outcome of expectant management of spontaneous first trimester miscarriage: observational study BMJ. 2002;324:873.

Chung TK, Cheung LP, Lau WC, Haines CJ, Chang AM. Spontaneous abortion: a medical approach to management. AusT N.Z. J Obstet Gynaecol. 1994;34:432-6.

Demetroulis C1, Saridogan E, Kunde D, Naftalin AA. A prospective randomized control trial comparing medical and surgical treatment for early pregnancy failure. Hum Reprod. 2001;16:365-9.

el-Refaey H, Rajasekar D, Abdalla M, Calder L, Templeton A. Induction of abortion with Mifepristone (RU 486) and oral or vaginal misoprostol. N Engl J Med. 1995;332:983-7.

Zieman M, Fong SK, Benowitz NL, Banskter D, Darney PD. Absorption kinetics of misoprostol with oral or vaginal administration. Obstet Gynecol. 1997;90:88-92.

Herabutya Y, O-Prasertsawat P. Misoprostol in the management of missed abortion. Int J Gynecol Obstet. 51997;6:263-6.

WHO Task Force. WHO task force on post-ovulatory methods of fertility regulation. Termination of pregnancy with reduced doses of mifepristone. Br Med J. 1993;307:532-7.

El-Refaey H, Templeton A. Early induction of abortion by a combination of mifepristone and misoprostol administered by the vaginal route. Contraception, 1994;49:111-4.

Ashok PW, Penney GC, Flett GM, Templeton A. An effective regimen for early medical abortion: a report of 2000 consecutive cases. Hum Reprod. 1998;13:2962-5.